ANDREE BREAUX: Open Payments
NPI 1639199672 · SHREVEPORT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,303 in 114 payments from 34 companies in 2025. Trend: 2023 $1,617 · 2024 $1,722 · 2025 $2,303
Food & beverage: $2,203Education: $100
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 14 | $332 |
| ABBVIE INC. | 12 | $250 |
| Janssen Biotech, Inc. | 9 | $231 |
| AstraZeneca Pharmaceuticals LP | 9 | $167 |
| Novartis Pharmaceuticals Corporation | 11 | $162 |
| PFIZER INC. | 10 | $155 |
| Stemline Therapeutics Inc. | 8 | $138 |
| Gilead Sciences, Inc. | 1 | $135 |
| Astellas Pharma US Inc | 5 | $80 |
| Merck Sharp & Dohme LLC | 3 | $60 |
Products named: Enhertu, EPKINLY, Orserdu, Trodelvy, TALVEY, Fabhalta, DARZALEX, CALQUENCE.
Industry payments across LA — which companies pay providers there.
